Asia Pacific Botulinum Toxin Market Size, Share & Industry Trends Analysis Report By Product, By Application (Therapeutic and Aesthetic), By End User (Hospitals, Dermatology Clinics and Spas & Cosmetic Centers, By Country and Growth Forecast, 2022 - 2028

The Asia Pacific Botulinum Toxin Market would witness market growth of 11.4% CAGR during the forecast period (2022-2028).

All cholinergic postganglionic sympathetic and parasympathetic neurons are affected by the toxin's inhibition of acetylcholine release. Due to this, there has been a number of studies on its usage as a therapy for aberrant gland activity or overactive smooth muscles, such as in achalasia. This has sparked interest in using it to treat aberrant gland activity or overactive smooth muscles, such as in achalasia. The toxin takes between 24 to 72 hours to start working, which corresponds to how long it takes to stop the synaptosomal process. In extremely exceptional situations, some people could need up to five days to observe the full effect.

A variety of conditions characterized by excessive muscular movement are treated with botulinum toxin, including cerebral palsy following a stroke, post-spinal cord injuries spasticity, and spasms of the head, neck, vagina, eyelid, limbs, jaw, and vocal cords. Similar to how it is used to relax tensed jaw muscles, esophageal muscles, bladder muscles, lower urinary tract muscles, and anus muscles that might aggravate the anal fissure. The botulinum toxin seems to work for persistent overactive bladder.

In India, chronic daily headaches, or CDH, are still mostly unstudied. There are many misconceptions, numerous unneeded investigations, and unsuitable therapies recommended. Headaches that occur more than 15 days a month for more than three months are referred to as CDH or chronic migraine. In a study of the National Library of Medicines, 849 instances (49.6% of all main headaches) were observed in India during the course of two years. This is becoming a subject of concern in the region.

The China market dominated the Asia Pacific Botulinum Toxin Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $845.6 Million by 2028.The Japan market is estimated to grow a CAGR of 10.7% during (2022 - 2028). Additionally, The India market would experience a CAGR of 12% during (2022 - 2028).

Based on Product, the market is segmented into Type A and Type B. Based on Application, the market is segmented into Therapeutic and Aesthetic. Based on End User, the market is segmented into Hospitals, Dermatology Clinics and Spas & Cosmetic Centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Free Valuable Insights: The Worldwide Botulinum Toxin Market is Projected to reach USD 10.5 Billion by 2028, at a CAGR of 10.8%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Evolus, Inc. (Alphaeon Corporation), Merz Pharma GmbH & Co. KGaA, AbbVie, Inc., Ipsen Pharma, Galderma S.A., USWM, LLC, and Metabiologics, Inc. (Object Pharma).

Scope of the Study

Market Segments Covered in the Report:

By Product

• Type A
• Type B

By Application

• Therapeutic
• Aesthetic

By End User

• Hospitals
• Dermatology Clinics
• Spas & Cosmetic Centers

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

• Evolus, Inc. (Alphaeon Corporation)
• Merz Pharma GmbH & Co. KGaA
• AbbVie, Inc.
• Ipsen Pharma
• Galderma S.A.
• USWM, LLC
• Metabiologics, Inc. (Object Pharma)

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Botulinum Toxin Market, by Product
1.4.2 Asia Pacific Botulinum Toxin Market, by Application
1.4.3 Asia Pacific Botulinum Toxin Market, by End User
1.4.4 Asia Pacific Botulinum Toxin Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Botulinum Toxin Market

Chapter 4. Asia Pacific Botulinum Toxin Market by Product
4.1 Asia Pacific Type A Market by Country
4.2 Asia Pacific Type B Market by Country

Chapter 5. Asia Pacific Botulinum Toxin Market by Application
5.1 Asia Pacific Therapeutic Market by Country
5.2 Asia Pacific Aesthetic Market by Country

Chapter 6. Asia Pacific Botulinum Toxin Market by End User
6.1 Asia Pacific Hospitals Market by Country
6.2 Asia Pacific Dermatology Clinics Market by Country
6.3 Asia Pacific Spas & Cosmetic Centers Market by Country

Chapter 7. Asia Pacific Botulinum Toxin Market by Country
7.1 China Botulinum Toxin Market
7.1.1 China Botulinum Toxin Market by Product
7.1.2 China Botulinum Toxin Market by Application
7.1.3 China Botulinum Toxin Market by End User
7.2 Japan Botulinum Toxin Market
7.2.1 Japan Botulinum Toxin Market by Product
7.2.2 Japan Botulinum Toxin Market by Application
7.2.3 Japan Botulinum Toxin Market by End User
7.3 India Botulinum Toxin Market
7.3.1 India Botulinum Toxin Market by Product
7.3.2 India Botulinum Toxin Market by Application
7.3.3 India Botulinum Toxin Market by End User
7.4 South Korea Botulinum Toxin Market
7.4.1 South Korea Botulinum Toxin Market by Product
7.4.2 South Korea Botulinum Toxin Market by Application
7.4.3 South Korea Botulinum Toxin Market by End User
7.5 Singapore Botulinum Toxin Market
7.5.1 Singapore Botulinum Toxin Market by Product
7.5.2 Singapore Botulinum Toxin Market by Application
7.5.3 Singapore Botulinum Toxin Market by End User
7.6 Malaysia Botulinum Toxin Market
7.6.1 Malaysia Botulinum Toxin Market by Product
7.6.2 Malaysia Botulinum Toxin Market by Application
7.6.3 Malaysia Botulinum Toxin Market by End User
7.7 Rest of Asia Pacific Botulinum Toxin Market
7.7.1 Rest of Asia Pacific Botulinum Toxin Market by Product
7.7.2 Rest of Asia Pacific Botulinum Toxin Market by Application
7.7.3 Rest of Asia Pacific Botulinum Toxin Market by End User

Chapter 8. Company Profiles
8.1 Evolus, Inc. (Alphaeon Corporation)
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Research & Development Expenses
8.1.4 Recent strategies and developments:
8.1.4.1 Approvals and Trials:
8.2 Merz Pharma GmbH & Co. KGaA
8.2.1 Company Overview
8.2.2 Recent strategies and developments:
8.2.2.1 Approvals and Trials:
8.3 AbbVie, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.5.2 Approvals and Trials:
8.4 Ipsen Pharma
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Galderma S.A.
8.5.1 Company Overview
8.5.2 Recent strategies and developments:
8.5.2.1 Geographical Expansions:
8.6 USWM, LLC
8.6.1 Company Overview
8.7 Metabiologics, Inc. (Object Pharma, Inc.)
8.7.1 Company Overview

TABLE 1 Asia Pacific Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Type A Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Type A Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Type B Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Type B Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Therapeutic Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Therapeutic Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Aesthetic Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Aesthetic Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Hospitals Market by Country, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Hospitals Market by Country, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Dermatology Clinics Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Dermatology Clinics Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Spas & Cosmetic Centers Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Spas & Cosmetic Centers Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Botulinum Toxin Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Botulinum Toxin Market by Country, 2022 - 2028, USD Million
TABLE 25 China Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 26 China Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 27 China Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 28 China Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 29 China Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 30 China Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 31 China Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 32 China Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 33 Japan Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 34 Japan Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 35 Japan Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 36 Japan Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 37 Japan Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 38 Japan Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 39 Japan Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 40 Japan Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 41 India Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 42 India Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 43 India Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 44 India Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 45 India Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 46 India Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 47 India Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 48 India Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 49 South Korea Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 50 South Korea Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 51 South Korea Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 52 South Korea Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 53 South Korea Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 54 South Korea Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 55 South Korea Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 56 South Korea Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 57 Singapore Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 58 Singapore Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 59 Singapore Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 60 Singapore Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 61 Singapore Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 62 Singapore Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 63 Singapore Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 64 Singapore Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 65 Malaysia Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 66 Malaysia Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 67 Malaysia Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 68 Malaysia Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 69 Malaysia Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 70 Malaysia Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 71 Malaysia Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 72 Malaysia Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 73 Rest of Asia Pacific Botulinum Toxin Market, 2018 - 2021, USD Million
TABLE 74 Rest of Asia Pacific Botulinum Toxin Market, 2022 - 2028, USD Million
TABLE 75 Rest of Asia Pacific Botulinum Toxin Market by Product, 2018 - 2021, USD Million
TABLE 76 Rest of Asia Pacific Botulinum Toxin Market by Product, 2022 - 2028, USD Million
TABLE 77 Rest of Asia Pacific Botulinum Toxin Market by Application, 2018 - 2021, USD Million
TABLE 78 Rest of Asia Pacific Botulinum Toxin Market by Application, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Botulinum Toxin Market by End User, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Botulinum Toxin Market by End User, 2022 - 2028, USD Million
TABLE 81 Key information – Evolus, Inc.
TABLE 82 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 83 Key information – AbbVie, Inc.
TABLE 84 Key Information – Ipsen Pharma
TABLE 85 Key Information – Galderma S.A.
TABLE 86 Key Information – USWM, LLC
TABLE 87 Key Information – Metabiologics, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: AbbVie, Inc.